Fundraising Fox

Evelo Biosciences

Cambridge, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

NB
Noubar B. Afeyan, Ph.D.Director
JG
Jennifer GlennonExecutive Officer
B(
Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
DR
David R. EpsteinDirector
LA
Lord Ara DarziDirector
DM
Duncan McHaleExecutive Officer
DP
David P. PerryDirector
WD
William DeVaulExecutive Officer
MB
Mark Bodmer, Ph.D.Executive Officer
TM
Theodose Melas-KyriaziDirector

Investors · 1

SV Health InvestorsBoston · $1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$81.5MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Noubar B. Afeyan, Ph.D.Director
  • Jennifer GlennonExecutive Officer
  • Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
  • David R. EpsteinDirector
  • Lord Ara DarziDirector
  • Duncan McHaleExecutive Officer
  • David P. PerryDirector
  • William DeVaulExecutive Officer
  • Mark Bodmer, Ph.D.Executive Officer
  • Theodose Melas-KyriaziDirector
Offering amount
$81.5M
Amount sold
$81.5M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedFeb 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
  • David P. PerryDirector
  • David A. Berry, M.D., Ph.D.Director
  • Mark Bodmer, Ph.D.Executive Officer
  • William DeVaulExecutive Officer
  • Jennifer GlennonExecutive Officer
  • Theodose Melas-KyriaziDirector
  • Lord Ara DarziDirector
  • David R. EpsteinDirector
  • Duncan McHaleExecutive Officer
  • Noubar B. Afeyan, Ph.D.Director
Offering amount
$50M
Amount sold
$50M
First sale
Jan 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.